日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Responsiveness of different MET tumour alterations to type I and type II MET inhibitors.

不同MET肿瘤改变对I型和II型MET抑制剂的反应性

Murciano-Goroff Yonina R, Foglizzo Valentina, Chang Jason, Rekhtman Natasha, Sisk Ann Elizabeth, Gibson Jamie, Judka Lia, Clemens Kristen, Roa Paola, Ahmed Shaza Sayed, Bremer Nicole V, Binaco Courtney Lynn, Muzungu Sherifah Kemigisha, Rodriguez Estelamari, Merrill Madeline, Sgroe Erica, Repetto Matteo, Stadler Zsofia K, Berger Michael F, Yu Helena A, Toska Eneda, Kannan Srinivasaraghavan, Verma Chandra S, Drilon Alexander, Cocco Emiliano

Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment

PI3K或AKT抑制剂治疗期间高血糖的特征、管理和危险因素

Liu, Dazhi; Weintraub, Michael A; Garcia, Christine; Goncalves, Marcus D; Sisk, Ann Elizabeth; Casas, Alissa; Harding, James J; Harnicar, Stephen; Drilon, Alexander; Jhaveri, Komal; Flory, James H